IP6K2 anticorps
-
- Antigène Voir toutes IP6K2 Anticorps
- IP6K2 (Inositol Hexakisphosphate Kinase 2 (IP6K2))
- Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp IP6K2 est non-conjugé
-
Application
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Attributs du produit
- Polyclonal Antibody
- Purification
- Antigen affinity purification
- Immunogène
- Synthetic peptide of human IP6K2
- Isotype
- IgG
- Top Product
- Discover our top product IP6K2 Anticorps primaire
-
-
- Indications d'application
- WB 1:500-1:2000, IHC 1:30-1:150, ELISA 1:5000-1:10000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.26 mg/mL
- Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- IP6K2 (Inositol Hexakisphosphate Kinase 2 (IP6K2))
- Autre désignation
- IP6K2 (IP6K2 Produits)
- Synonymes
- anticorps IHPK2, anticorps ip6k2, anticorps ihpk2, anticorps cb1087, anticorps wu:fb47g07, anticorps wu:fi24d03, anticorps ihpk2b, anticorps MGC69075, anticorps ihpk2a, anticorps MGC84167, anticorps PIUS, anticorps Ihpk2, anticorps Pius, anticorps 1500005N04Rik, anticorps AW050208, anticorps inositol hexakisphosphate kinase 2, anticorps inositol hexaphosphate kinase 2, anticorps inositol hexakisphosphate kinase 2a, anticorps inositol hexaphosphate kinase 2 L homeolog, anticorps inositol hexakisphosphate kinase 2b, anticorps inositol hexaphosphate kinase 2 S homeolog, anticorps IP6K2, anticorps ip6k2, anticorps ip6k2a, anticorps ip6k2.L, anticorps ip6k2b, anticorps ip6k2.S, anticorps MCYG_02913, anticorps Ip6k2
- Sujet
- This gene encodes a protein that belongs to the inositol phosphokinase (IPK) family. This protein is likely responsible for the conversion of inositol hexakisphosphate (InsP6) to diphosphoinositol pentakisphosphate (InsP7/PP-InsP5). It may also convert 1,3,4,5,6-pentakisphosphate (InsP5) to PP-InsP4 and affect the growth suppressive and apoptotic activities of interferon-beta in some ovarian cancers. Alternative splicing results in multiple transcript variants encoding different isoforms.
- Poids moléculaire
-
Observed_MW: Refer to figures
Calculated_MW: 49 kDa
- UniProt
- Q9UHH9
-